Eden Research plc (LON:EDEN – Get Free Report) shares shot up 2.8% during mid-day trading on Tuesday following insider buying activity. The company traded as high as GBX 4.18 ($0.05) and last traded at GBX 3.70 ($0.05). 12,234,783 shares were traded during mid-day trading, an increase of 664% from the average session volume of 1,602,016 shares. The stock had previously closed at GBX 3.60 ($0.04).
Specifically, insider Alexander John Abrey acquired 540,540 shares of Eden Research stock in a transaction dated Tuesday, January 28th. The stock was bought at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($26,919.32).
Eden Research Stock Down 3.7 %
The firm has a 50-day moving average of GBX 3.89 and a 200 day moving average of GBX 4.01. The company has a debt-to-equity ratio of 1.25, a current ratio of 3.80 and a quick ratio of 2.42. The stock has a market capitalization of £20.80 million, a price-to-earnings ratio of -200.00 and a beta of 0.92.
About Eden Research
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
Featured Articles
- Five stocks we like better than Eden Research
- What Are Dividend Challengers?
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- 3 Steel Stocks Soaring After Tariff Announcements
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.
